BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26658664)

  • 1. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
    Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
    Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
    Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
    Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
    Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
    Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions.
    Pham-Ledard A; Cowppli-Bony A; Doussau A; Prochazkova-Carlotti M; Laharanne E; Jouary T; Belaud-Rotureau MA; Vergier B; Merlio JP; Beylot-Barry M
    Am J Clin Pathol; 2015 Mar; 143(3):362-73. PubMed ID: 25696794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous vs secondary cutaneous follicular lymphomas: A comparative study focused on BCL2, CD10, and t(14;18) expression.
    Servitje O; Climent F; Colomo L; Ruiz N; García-Herrera A; Gallardo F; Mercadal S; Pomares H; Muniesa C; Martin-Callizo C; Marcoval J; Rovira R; Estrach T; Pujol RM
    J Cutan Pathol; 2019 Mar; 46(3):182-189. PubMed ID: 30511443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis.
    Abdul-Wahab A; Tang SY; Robson A; Morris S; Agar N; Wain EM; Child F; Scarisbrick J; Neat M; Whittaker S
    J Am Acad Dermatol; 2014 Jun; 70(6):1010-20. PubMed ID: 24679486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas.
    Vergier B; Belaud-Rotureau MA; Benassy MN; Beylot-Barry M; Dubus P; Delaunay M; Garroste JC; Taine L; Merlio JP
    Am J Surg Pathol; 2004 Jun; 28(6):748-55. PubMed ID: 15166666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.
    Siddiqi IN; Friedman J; Barry-Holson KQ; Ma C; Thodima V; Kang I; Padmanabhan R; Dias LM; Kelly KR; Brynes RK; Kamalakaran S; Houldsworth J
    Mod Pathol; 2016 Jun; 29(6):570-81. PubMed ID: 26965583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas.
    Streubel B; Scheucher B; Valencak J; Huber D; Petzelbauer P; Trautinger F; Weihsengruber F; Mannhalter C; Cerroni L; Chott A
    Am J Surg Pathol; 2006 Apr; 30(4):529-36. PubMed ID: 16625101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
    Schrader AMR; Jansen PM; Vermeer MH; Kleiverda JK; Vermaat JSP; Willemze R
    Am J Surg Pathol; 2018 Nov; 42(11):1488-1494. PubMed ID: 30113335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
    Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
    Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
    Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH
    Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma.
    Fernandez-Pol S; Bangs CD; Cherry A; Arber DA; Gratzinger D
    Hum Pathol; 2016 Sep; 55():39-43. PubMed ID: 27134111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.
    Yanai S; Nakamura S; Takeshita M; Fujita K; Hirahashi M; Kawasaki K; Kurahara K; Sakai Y; Matsumoto T
    Cancer; 2011 Jun; 117(11):2467-77. PubMed ID: 24048795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous follicle center lymphoma with Hodgkin and Reed-Sternberg-like cells: a new histopathologic variant.
    Dilly M; Ben-Rejeb H; Vergier B; Feldis M; Toty L; Nohra O; Beylot-Barry M; Gros A; Merlio JP; Parrens M
    J Cutan Pathol; 2014 Oct; 41(10):797-801. PubMed ID: 25099172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.
    Adam P; Baumann R; Schmidt J; Bettio S; Weisel K; Bonzheim I; Fend F; Quintanilla-Martínez L
    Hum Pathol; 2013 Sep; 44(9):1817-26. PubMed ID: 23642737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous presentation of follicular lymphomas.
    Franco R; Fernández-Vázquez A; Mollejo M; Cruz MA; Camacho FI; García JF; Navarrete M; Piris MA
    Mod Pathol; 2001 Sep; 14(9):913-9. PubMed ID: 11557789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH/BCL2.
    Gollub W; Stassek B; Huckhagel T; Bernd HW; Krokowski M; Merz H; Feller AC; Thorns C
    Anticancer Res; 2009 Nov; 29(11):4649-55. PubMed ID: 20032416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial lack of BCL2 in follicular lymphoma: An unusual immunohistochemical staining pattern explained by ongoing BCL2 mutation.
    van den Brand M; Garcia-Garcia M; Mathijssen JJ; Colomo L; Groenen PJ; Serrano S; van Krieken JH
    Pathol Res Pract; 2016 Feb; 212(2):148-50. PubMed ID: 26725534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
    Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
    Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.